See related research by Setzer *et al*., <http://ccforum.com/content/17/3/R99>

In the previous issue of *Critical Care*, Setzer and colleagues \[[@B1]\] describe an interesting set of experiments in which ventilation with large tidal volumes is associated with enhanced inflammatory changes and excess mortality in elderly rats compared to their younger counterparts. It is now well established that over-distention of the alveoli can damage alveolar lining cells and result in local and systemic inflammatory immune responses that can be deleterious to the host, even in the absence of pulmonary infection \[[@B2]\]. This problem, known as ventilator-induced lung injury (VILI), is a major, yet avoidable, complication of mechanical ventilation. Low tidal volume ventilatory strategies have now become the standard of care given the findings of the ARDSnet trial \[[@B3]\] and other supporting studies \[[@B4]\] and are now part of the Surviving Sepsis Campaign guidelines to limit ventilator-associated lung injury \[[@B5]\].

In the United States, elderly people (aged \>65 years) comprised 12.4% of the population in the year 2000, with an expected growth to 19% by the year 2030 \[[@B6]\]. Similar population changes are expected in many countries over the next several decades. Pneumonia remains a major source of morbidity in seniors, and the incidence of disease rises steadily with advanced age \[[@B7]\]. In 2011, the incidence of hospitalization for pneumonia, chronic obstructive pulmonary disease, and sepsis among people aged \>65 years in the US was just over 1.5 million/year \[[@B8]\] with a substantial number of these patients needing ventilatory support. The work of Setzer and colleagues indicates that elderly mammals (rats in their study) are more susceptible to VILI than younger animals. It is logical to assume that this excess risk of VILI in older mammals extends to *Homo sapiens*. If this is indeed the case, great care should be taken to avoid this preventable complication in older patients receiving mechanical ventilation.

Elderly patients are already known to be more vulnerable to infection due to the development of immune-senescence - a specific process characterized by a rather profound set of defects in immune function observed with aging \[[@B9]\]. B lymphocyte responses are markedly blunted and manifest by poor vaccine response rates and susceptibility to encapsulated bacterial pathogens \[[@B10],[@B11]\]. Cell-mediated immune function with both CD4 and CD8 cells are markedly impaired with advanced age and explain the increased susceptibility of older patients to tuberculosis, listeria infections, viral pathogens and a number of intracellular microbial pathogens \[[@B12]\]. While the adaptive immune response is characterized by gradual depression over time, the same situation is not observed with innate immune responses. Innate immune responses are either maintained or even enhanced in the elderly. Older patients are less capable of rapid resolution of inflammatory responses. Patients aged over 60 years exposed to standard endotoxin challenge develop more pronounced and prolonged reductions in mean arterial blood pressure compared to younger volunteers and have a greater likelihood of fever and tumor necrosis factor elevation \[[@B9],[@B13]\].

Based upon these age-related immune dysfunctions, it is perhaps not surprising that older rats had more pronounced immunologic injury compared to younger animals. It is reasonable to expect that the same will be true in elderly patients on mechanical ventilators versus younger patients. All of this has yet to be clearly demonstrated. The study has at least two important implications for critical care specialists and researchers. First, use extra care in choosing lung-protective strategies for older, mechanically ventilated patients in the intensive care unit. A search of existing data bases or future prospective studies should be undertaken to determine the degree to which age plays a part in susceptibility to VILI. The second implication is also an important one: we should study old animals in preclinical studies in sepsis, acute lung injury in general and VILI in particular. These pathologic processes are primarily seen in the elderly. In the animal research laboratory, young, healthy animals are the traditional experimental subjects for pneumonia, sepsis and lung injury studies. We know that the immune response of elderly animals and humans clearly differs from younger animals and patients. We have enough trouble extrapolating animal data to human pathophysiology without further confusing the issue by studying young animals and comparing them with old adult patients \[[@B14]\].

Older animals are usually not studied because of the expense and extra animal husbandry to maintain animals until they have aged (approximately 2 to 3 years for mice and rats). Data from this study and other studies in elderly experimental animals suggest that it may be worth the wait, and provide greater information than the standard experimental models using young, healthy animals \[[@B1],[@B9]\]. The investigators are to be congratulated for making this point in their experimental study, and hopefully this will stimulate other groups to use older animals in their experimental protocols.
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VILI: ventilator-induced lung injury.
